The blood-brain barrier effectively shields the brain parenchyma from a number of potentially neurotoxic substances. This is achieved in virtue of expression of specific zipper-like proteins that join neighboring endothelial cells. In addition to this cellular barrier, endothelial cells also express multiple drug resistance (MDR)-related proteins that act as extruders of a number of drugs that would otherwise significantly contribute to treatment of a number of central nervous system disorders including epilepsy. We have shown upregulation of MDR gene expression in endothelial cells isolated from human epileptic vs. non-epileptic brain. We have also unveiled an abnormal pattern of MDR expression in 1 """"""""epileptic"""""""" glia. To further our knowledge on the mechanisms involved in the development of pharmacoresistance to antiepileptic drugs (AED) we propose: 1) To study patterns of MDR gene expression across different epileptic pathologies compared to non-epileptic brain; 2) To determine the cellular distribution of MDR gene products in epileptic compared to non-epileptic cortex; 3) To test the hypothesis that breakdown of the blood-brain barrier is an early event leading to pharmacoresistance and expression of MDR in perivascular glia; and 4) To determine the AED permeability across and """"""""epileptic"""""""" blood-brain barrier model compared to non-MDR expressing endothelial cells and glia. We propose to use a multidisciplinary approach combining molecular biology, protein analysis and functional studies; these studies will be performed on freshly isolated surgical specimens characterized by their epileptogenic (or normal) electrical activity by a team of neurosurgeons and neurologists. The long-term goal of this laboratory is to understand interactions between neuronal and non-neuronal cells in health and disease. In particular, we are investigating how changes in blood-brain barrier function may drive glia and neurons into an """"""""epileptic"""""""" phenotype.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS043284-04
Application #
6878018
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Fureman, Brandy E
Project Start
2002-04-01
Project End
2006-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
4
Fiscal Year
2005
Total Cost
$327,038
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Choi, Humberto; Puvenna, Vikram; Brennan, Chanda et al. (2016) S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer. Transl Lung Cancer Res 5:413-9
Dadas, Aaron; Washington, Jolewis; Marchi, Nicola et al. (2016) Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers. Fluids Barriers CNS 13:21
Ghosh, Chaitali; Hossain, Mohammed; Solanki, Jesal et al. (2016) Pathophysiological implications of neurovascular P450 in brain disorders. Drug Discov Today 21:1609-1619
Puvenna, Vikram; Engeler, Madeline; Banjara, Manoj et al. (2016) Is phosphorylated tau unique to chronic traumatic encephalopathy? Phosphorylated tau in epileptic brain and chronic traumatic encephalopathy. Brain Res 1630:225-40
Falcone, Tatiana; Carlton, Erin; Lee, Catherine et al. (2015) Does Systemic Inflammation Play a Role in Pediatric Psychosis? Clin Schizophr Relat Psychoses 9:65-78B
Ghosh, Chaitali; Hossain, Mohammad; Spriggs, Addison et al. (2015) Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study. Epilepsia 56:439-49
Falcone, Tatiana; Janigro, Damir; Lovell, Rachel et al. (2015) S100B blood levels and childhood trauma in adolescent inpatients. J Psychiatr Res 62:14-22
Janigro, Damir; Walker, Matthew C (2014) What non-neuronal mechanisms should be studied to understand epileptic seizures? Adv Exp Med Biol 813:253-64
Puvenna, Vikram; Brennan, Chanda; Shaw, Gerald et al. (2014) Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits. PLoS One 9:e96296
Bargerstock, Erin; Puvenna, Vikram; Iffland, Philip et al. (2014) Is peripheral immunity regulated by blood-brain barrier permeability changes? PLoS One 9:e101477

Showing the most recent 10 out of 63 publications